These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16363279

  • 1. The response of skin perfusion and of rheological and immunological variables to intravenous prostanoid administration in Raynaud's phenomenon secondary to collagenosis.
    Drinda S, Neumann T, Pöhlmann G, Vogelsang H, Stein G, Wolf G, Hein G.
    Vasa; 2005 Nov; 34(4):243-9. PubMed ID: 16363279
    [Abstract] [Full Text] [Related]

  • 2. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z.
    Auton Neurosci; 2004 Nov 30; 116(1-2):62-8. PubMed ID: 15556839
    [Abstract] [Full Text] [Related]

  • 3. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM, Seibold JR, Wise RA, McCloskey DA, Dole WP.
    J Rheumatol; 1992 Sep 30; 19(9):1407-14. PubMed ID: 1279170
    [Abstract] [Full Text] [Related]

  • 4. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
    Kanetaka T, Komiyama T, Onozuka A, Miyata T, Shigematsu H.
    Eur J Vasc Endovasc Surg; 2004 Apr 30; 27(4):414-6. PubMed ID: 15015193
    [Abstract] [Full Text] [Related]

  • 5. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R, Shariat K, von Wilmowsky H, Böhm M.
    Circulation; 2005 Nov 08; 112(19):2980-5. PubMed ID: 16275885
    [Abstract] [Full Text] [Related]

  • 6. [Effects of long-term iloprost therapy on Raynaud's phenomenon in progressive systemic sclerosis].
    Cordioli E, Virgilio S, Ghirardi R, Martinelli M.
    Minerva Med; 1992 Nov 08; 83(11):739-44. PubMed ID: 1281297
    [Abstract] [Full Text] [Related]

  • 7. Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study.
    Kawald A, Burmester GR, Huscher D, Sunderkötter C, Riemekasten G.
    J Rheumatol; 2008 Sep 08; 35(9):1830-7. PubMed ID: 18634152
    [Abstract] [Full Text] [Related]

  • 8. Comparison between iloprost and alprostadil in the treatment of Raynaud's phenomenon.
    Marasini B, Massarotti M, Bottasso B, Coppola R, Del Papa N, Maglione W, Comina DP, Maioli C.
    Scand J Rheumatol; 2004 Sep 08; 33(4):253-6. PubMed ID: 15370722
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Laser-Doppler measurement of digital blood flow regulation in normals and in patients with Raynaud's phenomenon.
    Kristensen JK, Engelhart M, Nielsen T.
    Acta Derm Venereol; 1983 Sep 08; 63(1):43-7. PubMed ID: 6191488
    [Abstract] [Full Text] [Related]

  • 14. [The influence of isosorbide mononitrate on skin blood flow in patients with Raynaud's syndrome].
    Gross R, Galus K, Zajac S, Jedrasik M.
    Wiad Lek; 2002 Sep 08; 55(1-2):29-34. PubMed ID: 12043312
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Sarpogrelate hydrochloride for Raynaud's phenomenon of patients with collagen diseases].
    Kumagai S, Morinobu A, Ozaki S, Nakao K, Ishida H.
    Ryumachi; 1998 Jun 08; 38(3):504-10. PubMed ID: 9721558
    [Abstract] [Full Text] [Related]

  • 17. [Raynaud's phenomenon and blood viscosity].
    Lacombe C, Mouthon JM, Bucherer C, Lelievre JC, Bletry O, Godeau P.
    J Mal Vasc; 1992 Jun 08; 17 Suppl B():132-5. PubMed ID: 1602250
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.